Latest filing published 27 Dec 2023 for Solara Active Pharma Sciences Limited, €7.5M.
Filing timeline
BuySaleDevicam Capital LLP: trading record in brief
Devicam Capital LLP is a declared insider of Solara Active Pharma Sciences Limited, with filings sourced from SEBI (PIT + SAST). Between 22 June 2022 and 26 December 2023, the trades on record add up to 5 filings.
No open-market sale appears; the market trades are 2 purchases worth €6,610. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Most recently, on 27 December 2023, the filings show a transaction worth €7.5M in Solara Active Pharma Sciences Limited. The last insider purchase was made public on 16 August 2022, 1,545 days ago. Typically, a trade is published a median of 2 days after it takes place. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Companies and markets linked to Devicam Capital LLP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,013,747 shares@ ₹339.650733.2% of flowEquity SharesSEBI:48d4ed0af834f2ba94d1f7efa6a4c6096cdae8b6
- 1,400,000 shares@ ₹470.2533.7% of flowEquity SharesSEBI:ada69e9d7e254fec378783fb52082224ee32e1c2Canonical exit: 9 Mar 2023 (T+90)
- 583 shares@ ₹360.79420.0% of flowEquity SharesSEBI:cb20fd2736f75befd031b1f655fb37931f302287Canonical exit: 9 Nov 2022 (T+90)
- 916 shares@ ₹360.79480.0% of flowEquity SharesSEBI:fc434d4d07f7a7df9f521d554ce44c4ce9353189Canonical exit: 8 Nov 2022 (T+90)
- 1,500,000 shares@ ₹408.9033.0% of flowEquity SharesSEBI:d4fb722a9a95ca8212b1436a490556ac32374ab3Canonical exit: 20 Sept 2022 (T+90)
5 of 5 declarations